| Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer EH Romond, EA Perez, J Bryant, VJ Suman, CE Geyer Jr, NE Davidson, ... New England journal of medicine 353 (16), 1673-1684, 2005 | 7277 | 2005 |
| Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 JP Kuebler, HS Wieand, MJ O'Connell, RE Smith, LH Colangelo, ... Journal of clinical oncology 25 (16), 2198-2204, 2007 | 1370 | 2007 |
| Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer ANJ Tutt, JE Garber, B Kaufman, G Viale, D Fumagalli, P Rastogi, ... New England Journal of Medicine 384 (25), 2394-2405, 2021 | 1326 | 2021 |
| Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 MS Roh, LH Colangelo, MJ O'Connell, G Yothers, M Deutsch, CJ Allegra, ... Journal of clinical oncology 27 (31), 5124-5130, 2009 | 1160 | 2009 |
| Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in … E Tan-Chiu, G Yothers, E Romond, CE Geyer Jr, M Ewer, D Keefe, ... Journal of Clinical Oncology 23 (31), 7811-7819, 2005 | 1009 | 2005 |
| Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28 EP Mamounas, J Bryant, B Lembersky, L Fehrenbacher, SM Sedlacek, ... Journal of clinical oncology 23 (16), 3686-3696, 2005 | 850 | 2005 |
| Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses G Yothers, MJ O'Connell, CJ Allegra, JP Kuebler, LH Colangelo, ... Journal of clinical oncology 29 (28), 3768-3774, 2011 | 793 | 2011 |
| Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials D Sargent, A Sobrero, A Grothey, MJ O'Connell, M Buyse, T Andre, ... Journal of Clinical Oncology 27 (6), 872-877, 2009 | 774 | 2009 |
| Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08 CJ Allegra, G Yothers, MJ O'Connell, S Sharif, NJ Petrelli, LH Colangelo, ... Journal of Clinical Oncology 29 (1), 11-16, 2011 | 750 | 2011 |
| DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy FA Sinicrope, NR Foster, SN Thibodeau, S Marsoni, G Monges, ... Journal of the National Cancer Institute 103 (11), 863-875, 2011 | 625 | 2011 |
| Real-world performance of HER2 testing—national surgical adjuvant breast and bowel project experience S Paik, J Bryant, E Tan-Chiu, E Romond, W Hiller, K Park, A Brown, ... Journal of the National Cancer Institute 94 (11), 852-854, 2002 | 617 | 2002 |
| Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus … EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ... Journal of Clinical Oncology 30 (31), 3792-3799, 2012 | 601 | 2012 |
| CDX2 as a prognostic biomarker in stage II and stage III colon cancer P Dalerba, D Sahoo, S Paik, X Guo, G Yothers, N Song, N Wilcox-Fogel, ... New England Journal of Medicine 374 (3), 211-222, 2016 | 558 | 2016 |
| Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04 MJ O'Connell, LH Colangelo, RW Beart, NJ Petrelli, CJ Allegra, S Sharif, ... Journal of clinical oncology 32 (18), 1927-1934, 2014 | 513 | 2014 |
| Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer JJ Dignam, BN Polite, G Yothers, P Raich, L Colangelo, MJ O'Connell, ... Journal of the National Cancer Institute 98 (22), 1647-1654, 2006 | 404 | 2006 |
| HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15 S Paik, J Bryant, E Tan-Chiu, G Yothers, C Park, DL Wickerham, ... JNCI: Journal of the National Cancer Institute 92 (24), 1991-1998, 2000 | 397 | 2000 |
| Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical … BC Lembersky, HS Wieand, NJ Petrelli, MJ O'Connell, LH Colangelo, ... Journal of Clinical Oncology 24 (13), 2059-2064, 2006 | 393 | 2006 |
| Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial CJ Allegra, G Yothers, MJ O’Connell, RW Beart, TF Wozniak, HC Pitot, ... Journal of the National Cancer Institute 107 (11), djv248, 2015 | 374 | 2015 |
| Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus … MJ O'Connell, I Lavery, G Yothers, S Paik, KM Clark-Langone, M Lopatin, ... Journal of clinical oncology 28 (25), 3937-3944, 2010 | 364 | 2010 |
| Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database NJ McCleary, JA Meyerhardt, E Green, G Yothers, A De Gramont, ... Journal of clinical oncology 31 (20), 2600-2606, 2013 | 357 | 2013 |
Soonmyung PaikYonsei University College of MedicineGeverifieerd e-mailadres voor yuhs.ac
